Hormone Franchise Courts Multi-Unit Operators With Cash-Pay Clinic Model

Men are paying more out of pocket for hormone health. Testosterone levels in men have declined steadily over recent decades, and demand for optimization clinics has grown as a result. That demand has caught the attention of franchise investors, who are now evaluating cash-pay hormone health concepts as a scalable business model outside traditional insurance-based medicine.

Castle Rock Hormone Health (CRHH) provides hormone therapy, medically guided weight loss, and anti-aging services for men and women. The company reports more than 10,000 patients served and over $10 million in annual revenue, with 25% year-over-year growth. It is targeting 100 to 250 new clinics in 2026 and aims for 1,000 locations nationally within five years.

The franchise uses standardized clinical protocols developed by co-founder and CMO Dr. Lee Moorer, supported by centralized training for clinical and non-clinical staff. Clinics operate on a membership basis, with consultations, lab review, and ongoing monitoring delivered in a concierge-style setting designed to support patient retention and revenue predictability.

CRHH is working with Franchise Sidekick, a national advisor network, to identify qualified candidates. The company says prospects are assessed for financial readiness and operator fit before entering the discovery process. Hormone optimization services for men, including testosterone therapy, represent a growing segment of the direct-pay health market the franchise is positioned to address.